–
Статьи в журналах
-
- 2023 Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the <scp>CLEAR</scp> trial
- Rha Sun Young, Choueiri Toni K., Matveev Vsevolod B., Alyasova Anna, Hong Sung‐Hoo, Gordoa Teresa Alonso, Gurney Howard, Bjarnason Georg A., Buchler Tomas, Pedrazzoli Paolo, Takagi Toshio, Park Se Hoon, Lee Jae Lyun, Perini Rodolfo F., He Cixin S., McKenzie Jodi A., Eto Masatoshi
- в журнале International Journal of Cancer, издательство John Wiley & Sons Inc. (United States), том 153, № 6, с. 1241-1250 DOI
-
- 2021 Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
- McDermott David F., Lee Jae-Lyun, Ziobro Marek, Suarez Cristina, Langiewicz Przemyslaw, Matveev Vsevolod Borisovich, Wiechno Pawel, Gafanov Rustem Airatovich, Tomczak Piotr, Pouliot Frederic, Donskov Frede, Alekseev Boris Yakovlevich, Shin Sang Joon, Bjarnason Georg A., Castellano Daniel, Silverman Rachel Kloss, Perini Rodolfo F., Schloss Charles, Atkins Michael B.
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 9, с. 1029-1039 DOI